Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation

Anti-Cancer Drugs

Volumn 20, Issue 6, 2009, Pages 437-443

  Woodall, Charles E ^a   Li, Yan ^a   Qia, Hong Liu ^a   Wo, John ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Barrett's esophagus; Chemoprevention; Esophageal adenocarcinoma; Resveratrol

Indexed keywords

RESVERATROL; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS ANASTOMOSIS; HISTOPATHOLOGY; INTESTINE METAPLASIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFLUX ESOPHAGITIS; TREATMENT OUTCOME;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CATALASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; METAPLASIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 67249143079     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32832afb95     Document Type: Article

References (18)

1. Wu X, Chen VW, Ruiz B, Andrews P, Su LJ, Correa P. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer 2006; 106:683-692. (Pubitemid 43157633)
2. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol 2001; 30:1415-1425. (Pubitemid 34134300)
3. Liu BL, Zhang X, Zhang W, Zhen HN. New enlightenment of French paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther 2007; 6:1833-1836. (Pubitemid 351590392)
4. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008; 10:475-510.
5. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 2007; 2:133-138. (Pubitemid 46957321)
6. Carneiro F, Chaves P. Pathologic risk factors of adenocarcinoma of the gastric cardia and gastroesophageal junction. Surg Oncol Clin N Am 2006; 15:697-714. (Pubitemid 44515145)
7. Li Y, Wo JM, Su RR, Ray MB, Martin RC. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol 2007; 14:2045-2055. (Pubitemid 46988261)
8. Martin RC, Liu Q, Wo JM, Ray MB, Li Y. Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin Cancer Res 2007; 13:5176-5182. (Pubitemid 47502087)
9. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58:163-174.
10. Li Y, Wo JM, Ellis S, Ray MB, Jones W, Martin RC. A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci 2006; 51:527-532.
11. Li Y, Wo JM, Su RR, Ray MB, Jones W, Martin RC. Esophageal injury with external esophageal perfusion. J Surg Res 2005; 129:107-113. (Pubitemid 41501862)
12. Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, et al. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 2002; 23:1531-1536. (Pubitemid 35012434)
13. Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9:408-411. (Pubitemid 36372096)
14. Sengottuvelan M, Viswanathan P, Nalini N. Chemopreventive effect of trans-resveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 2006; 27:1038-1046.
15. Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, El May M, Gharbi N, et al. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 2007; 80:1033-1039. (Pubitemid 46204723)
16. Kirimlioglu V, Karakayali H, Turkoglu S, Haberal M. Effect of resveratrol on oxidative stress enzymes in rats subjected to 70% partial hepatectomy. Transplant Proc 2008; 40:293-296. (Pubitemid 351186622)
17. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007; 16:1246-1252. (Pubitemid 46984966)
18. Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 2008; 658:68-94. (Pubitemid 351172881)